https://stanfordhealthcare.org/publications/929/929714.html
929714 | Stanford Health Care
Micro-dystrophin expression and safety with delandistrogene moxeparvovec gene therapy for DMD in a broad population: phase 1B trial (ENDEAVOR)
stanfordhealthcare